Search Results | American Association for Cancer Research

1-20 of 749

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Neoadjuvant Approaches in Hepatocellular Carcinoma: There's No Time Like the Present

Joseph W. Franses, Andrew X. Zhu

Clin Cancer Res (2022) 28 (13): 2738–2743.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-0025

Published: 01 July 2022

View article

Journal Articles

Metabolic reprogramming in hematological malignancies: advances and clinical perspectives

Xin Wang, Zhuoya Yu, Xiangxiang Zhou

Cancer Res can.22.0917.

DOI: https://doi.org/10.1158/0008-5472.CAN-22-0917

Published: 30 June 2022

View article

Journal Articles

Facts and Hopes in the Relationship of EBV with Cancer Immunity and Immunotherapy

Baochun Zhang, Il-Kyu Choi

Clin Cancer Res OF1–OF7.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-3408

Published: 27 June 2022

View article

Journal Articles

The central role of mTORC1 in amino acid sensing

Shusheng Yue, Guanya Li, Shanping He, Tingting Li

Cancer Res canres.4403.2021.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-4403

Published: 24 June 2022

View article

Journal Articles

Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy

Diwakar Davar, Hassane M. Zarour

Clin Cancer Res clincanres.1129.2022-1-19 13:21:38.193.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-1129

Published: 24 June 2022

View article

Journal Articles

Reproducibility of the blood and urine exposome - a systematic literature review and meta-analysis

Jantje Goerdten, Li Yuan, Inge Huybrechts, Vanessa Neveu, Ute Nöthlings, Wolfgang Ahrens, Augustin Scalbert, Anna Floegel

Cancer Epidemiol Biomarkers Prev cebp.0090.2022.

DOI: https://doi.org/10.1158/1055-9965.EPI-22-0090

Published: 23 June 2022

View article

Includes: Supplementary data

Journal Articles

PPM1D in Solid and Hematologic Malignancies: Friend and Foe?

Linda Zhang, Joanne I. Hsu, Margaret A. Goodell

Mol Cancer Res OF1–OF14.

DOI: https://doi.org/10.1158/1541-7786.MCR-21-1018

Published: 23 June 2022

View article

Journal Articles

Monounsaturated Fatty Acids: Key Regulators of Cell Viability and Intracellular Signaling in Cancer

Julia S. Scott, Zeyad D. Nassar, Johannes V. Swinnen, Lisa M. Butler

Mol Cancer Res OF1–OF11.

DOI: https://doi.org/10.1158/1541-7786.MCR-21-1069

Published: 23 June 2022

View article

Journal Articles

Inactivating amplified HER2: challenges, dilemmas, and future directions

Mark M. Moasser

Cancer Res canres.1121.2022.

DOI: https://doi.org/10.1158/0008-5472.CAN-22-1121

Published: 22 June 2022

View article

Journal Articles

Emerging Roles of the Copper–CTR1 Axis in Tumorigenesis

Yaqing Su, Xiaomei Zhang, Shaoqiang Li, Wei Xie, Jianping Guo

Mol Cancer Res OF1–OF15.

DOI: https://doi.org/10.1158/1541-7786.MCR-22-0056

Published: 16 June 2022

View article

Journal Articles

Oncogenic and Tumor-Suppressive Functions of the RNA Demethylase FTO

Hidde R. Zuidhof, Cornelis F. Calkhoven

Cancer Res (2022) 82 (12): 2201–2212.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-3710

Published: 15 June 2022

View article

Includes: Supplementary data

Journal Articles

Somatic Mutation: What Shapes the Mutational Landscape of Normal Epithelia?

Joanna C. Fowler, Philip H. Jones

Cancer Discov OF1–OF14.

DOI: https://doi.org/10.1158/2159-8290.CD-22-0145

Published: 07 June 2022

View article

Journal Articles

Cancer Immunoediting in the Era of Immuno-oncology

Matthew M. Gubin, Matthew D. Vesely

Clin Cancer Res OF1–OF12.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-1804

Published: 07 June 2022

View article

Journal Articles

Coming of Age: Human Genomics and the Cancer–Immune Set Point

Christian Hammer, Ira Mellman

Cancer Immunol Res (2022) 10 (6): 674–679.

DOI: https://doi.org/10.1158/2326-6066.CIR-21-1017

Published: 03 June 2022

View article

Journal Articles

RNA in Cancer Immunotherapy: Unlocking the Potential of the Immune System

Wout De Mey, Arthur Esprit, Kris Thielemans, Karine Breckpot, Lorenzo Franceschini

Clin Cancer Res OF1–OF11.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-3304

Published: 03 June 2022

View article

Journal Articles

A Road Map for Designing Phase I Clinical Trials of Radiotherapy–Novel Agent Combinations

Sarah R. Brown, Samantha Hinsley, Emma Hall, Chris Hurt, Richard D. Baird, Martin Forster, Andrew F. Scarsbrook, Richard A. Adams

Clin Cancer Res OF1–OF13.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-4087

Published: 03 June 2022

View article

Journal Articles

Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600–Mutant Tumors

Jacob J. Adashek, Arjun K. Menta, Neha K. Reddy, Aakash P. Desai, Jason Roszik, Vivek Subbiah

Mol Cancer Ther (2022) 21 (6): 871–878.

DOI: https://doi.org/10.1158/1535-7163.MCT-21-0950

Published: 01 June 2022

View article

Includes: Supplementary data

Journal Articles

Multicancer Early Detection Technologies: A Review Informed by Past Cancer Screening Studies

Sana Raoof, Richard J. Lee, Kunal Jajoo, Joseph D. Mancias, Timothy R. Rebbeck, Steven J. Skates

Cancer Epidemiol Biomarkers Prev (2022) 31 (6): 1139–1145.

DOI: https://doi.org/10.1158/1055-9965.EPI-21-1443

Published: 01 June 2022

View article

Journal Articles

Immunotherapy for Nonmelanoma Skin Cancer: Facts and Hopes

Sophia Z. Shalhout, Howard L. Kaufman, Kevin S. Emerick, David M. Miller

Clin Cancer Res (2022) 28 (11): 2211–2220.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-2971

Published: 01 June 2022

View article

Journal Articles

Molecular Pathways and Mechanisms of LAG-3 in Cancer Therapy

Lawrence P. Andrews, Anthony R. Cillo, Lilit Karapetyan, John M. Kirkwood, Creg J. Workman, Dario A.A. Vignali

Clin Cancer Res OF1–OF10.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-2390

Published: 26 May 2022

View article

2 3 4 5

NARROW

Neoadjuvant Approaches in Hepatocellular Carcinoma: There's No Time Like the Present

Metabolic reprogramming in hematological malignancies: advances and clinical perspectives

Facts and Hopes in the Relationship of EBV with Cancer Immunity and Immunotherapy

The central role of mTORC1 in amino acid sensing

Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy

Reproducibility of the blood and urine exposome - a systematic literature review and meta-analysis

PPM1D in Solid and Hematologic Malignancies: Friend and Foe?

Monounsaturated Fatty Acids: Key Regulators of Cell Viability and Intracellular Signaling in Cancer

Inactivating amplified HER2: challenges, dilemmas, and future directions

Emerging Roles of the Copper–CTR1 Axis in Tumorigenesis

Oncogenic and Tumor-Suppressive Functions of the RNA Demethylase FTO

Somatic Mutation: What Shapes the Mutational Landscape of Normal Epithelia?

Cancer Immunoediting in the Era of Immuno-oncology

Coming of Age: Human Genomics and the Cancer–Immune Set Point

RNA in Cancer Immunotherapy: Unlocking the Potential of the Immune System

A Road Map for Designing Phase I Clinical Trials of Radiotherapy–Novel Agent Combinations

Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600–Mutant Tumors

Multicancer Early Detection Technologies: A Review Informed by Past Cancer Screening Studies

Immunotherapy for Nonmelanoma Skin Cancer: Facts and Hopes

Molecular Pathways and Mechanisms of LAG-3 in Cancer Therapy

AACR Journals

AACR Journals

This Feature Is Available To Subscribers Only